Evidence map›Paper›PMID 25403742›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2015

Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation.

M Caralt, J S Uzarski, S Iacob, K P Obergfell, N Berg, B M Bijonowski, K M Kiefer, H H Ward, A Wandinger-Ness, W M Miller and 3 more

Erratum issuedAbstract readEvaluation Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Kidney-Derived ECM Hydrogels as Cell Delivery Devices.ACS applied materials & interfaces · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Biocompatibility of decellularized spinach leaves.npj biomedical innovations · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. The 3Rs in Experimental Liver Disease.Animals : an open access journal from MDPI · 2023
    Review
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

M CaraltComprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL; Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL; Servei Cirurgia HepatoBilioPancreatica i Trasplantaments, Hospital Universitari Vall Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
J S Uzarski
S Iacob
K P Obergfell
N Berg
B M Bijonowski
K M Kiefer
H H Ward
A Wandinger-Ness
W M Miller
Z J Zhang
M M Abecassis
J A Wertheim

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Pathologic Mechanisms of Polycystic Kidney DiseaseR01DK050141 · NIDDK · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 1995 to 2010
$2.7M
NCATS NIH HHS UL1 TR001422NCI NIH HHS NCI CA060553NCI NIH HHS NCI CCSG P30 CA060553NCI NIH HHS P30 CA060553NIDDK NIH HHS R01 DK050141NIGMS NIH HHS K12 GM088021PHS HHS NIDDK R01 DK050141PHS HHS NIGMS K12 GM088021
6 · The paper itself

Abstract

The ability to generate patient-specific cells through induced pluripotent stem cell (iPSC) technology has encouraged development of three-dimensional extracellular matrix (ECM) scaffolds as bioactive substrates for cell differentiation with the long-range goal of bioengineering organs for transplantation. Perfusion decellularization uses the vasculature to remove resident cells, leaving an intact ECM template wherein new cells grow; however, a rigorous evaluative framework assessing ECM structural and biochemical quality is lacking. To address this, we developed histologic scoring systems to quantify fundamental characteristics of decellularized rodent kidneys: ECM structure (tubules, vessels, glomeruli) and cell removal. We also assessed growth factor retention--indicating matrix biofunctionality. These scoring systems evaluated three strategies developed to decellularize kidneys (1% Triton X-100, 1% Triton X-100/0.1% sodium dodecyl sulfate (SDS) and 0.02% Trypsin-0.05% EGTA/1% Triton X-100). Triton and Triton/SDS preserved renal microarchitecture and retained matrix-bound basic fibroblast growth factor and vascular endothelial growth factor. Trypsin caused structural deterioration and growth factor loss. Triton/SDS-decellularized scaffolds maintained 3 h of leak-free blood flow in a rodent transplantation model and supported repopulation with human iPSC-derived endothelial cells and tubular epithelial cells ex vivo. Taken together, we identify an optimal Triton/SDS-based decellularization strategy that produces a biomatrix that may ultimately serve as a rodent model for kidney bioengineering.

Indexed as

Tissue EngineeringTissue ScaffoldsAnimalsCell DifferentiationCells, CulturedDetergentsEndothelium, VascularExtracellular MatrixHumansInduced Pluripotent Stem CellsKidney TubulesMaleOrgan TransplantationPerfusionRatsRats, Sprague-DawleyDetergentsanimal models: murine, bioengineering, kidney biology, stem cellsbasic (laboratory) research/scienceregenerative medicinetissue/organ engineering

Identifiers

PMID25403742
PMCPMC4276475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.